JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Targeting leishmaniasis with an entamoeba molecule
Current treatment approaches for leishmaniasis, a parasitic disease, consist mainly of chemotherapeutics, which can cause severe side effects for individuals and many perennial challenges for clinicians. This underscores the need for researchers to investigate new therapeutic methods that could be used independently or in conjunction with chemotherapeutics.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Targeting leishmaniasis with an entamoeba molecule